Barbara E Bierer

Barbara Emily Bierer, MD

Professor of Medicine (Pediatrics), HMS
Member, HMS Center for Bioethics

Barbara Bierer, MD is a Professor of Medicine (Pediatrics) at Harvard Medical School (HMS), and a hematologist/oncologist at the Brigham and Women's Hospital (BWH). She received her MD from HMS. She is the director of the Regulatory Foundations, Law and Ethics Program of the Harvard Catalyst, the Harvard Clinical and Translational Science Award, and the director of regulatory policy, SMART IRB. Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a University-wide and collaborative effort to improve the ethics, conduct, and regulatory environment for multi-site, multi-national clinical trials. She is a co-founder of COVID-19 Collaboration Platform, a platform for cooperation in research. In 2017, the MRCT Center launched the non-profit Vivli, a global clinical research data sharing platform. From 2003-2014, she served as Senior Vice President, Research, at BWH and was the institutional official for human subjects and animal research, for biosafety and for research integrity at the BWH. She initiated the Brigham Research Institute and the Innovation Hub (iHub), a focus for entrepreneurship and innovation. Dr. Bierer established and directed the Center for Faculty Development and Diversity at the BWH; for these efforts, she was the first recipient of the HMS Harold Amos Faculty Diversity Award.

Publications View
Lateral mobility of class I histocompatibility antigens in B lymphoblastoid cell membranes: modulation by cross-linking and effect of cell density.
Authors: Authors: Bierer BE, Herrmann SH, Brown CS, Burakoff SJ, Golan DE.
J Cell Biol
View full abstract on Pubmed
T3 glycoprotein is functional although structurally distinct on human T-cell receptor gamma T lymphocytes.
Authors: Authors: Krangel MS, Bierer BE, Devlin P, Clabby M, Strominger JL, McLean J, Brenner MB.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation.
Authors: Authors: Mentzer SJ, Remold-O'Donnell E, Crimmins MA, Bierer BE, Rosen FS, Burakoff SJ.
J Exp Med
View full abstract on Pubmed
Abnormal cytolytic activity of lymphocyte function-associated antigen-1-deficient human cytolytic T lymphocyte clones.
Authors: Authors: Mentzer SJ, Bierer BE, Anderson DC, Springer TA, Burakoff SJ.
J Clin Invest
View full abstract on Pubmed
Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells.
Authors: Authors: Bringhurst FR, Bierer BE, Godeau F, Neyhard N, Varner V, Segre GV.
J Clin Invest
View full abstract on Pubmed
The role of functional cell surface antigens in T cell activation.
Authors: Authors: Bierer BE, Mentzer SJ, Greenstein JL, Burakoff SJ.
Year Immunol
View full abstract on Pubmed
Q-T prolongation and torsades de pointes ventricular tachycardia produced by the tetracyclic antidepressant agent maprotiline.
Authors: Authors: Herrmann HC, Kaplan LM, Bierer BE.
Am J Cardiol
View full abstract on Pubmed
The treatment of sickle cell anemia with induced hyponatremia.
Authors: Authors: Rosa RM, Bierer BE, Bunn HF, Epstein FH.
Blood Cells
View full abstract on Pubmed
A study of induced hyponatremia in the prevention and treatment of sickle-cell crisis.
Authors: Authors: Rosa RM, Bierer BE, Thomas R, Stoff JS, Kruskall M, Robinson S, Bunn HF, Epstein FH.
N Engl J Med
View full abstract on Pubmed
Prevention and treatment of sickle cell crisis by induced hyponatremia.
Authors: Authors: Rosa RM, Bierer B, Thomas R, Stoff JS, Kruskall M, Robinson S, Bunn HF, Epstein FH.
Trans Assoc Am Physicians
View full abstract on Pubmed